Clinical Trial Update: Downstaging Prediction Model for HCC

View source ↗

Summary

An update on a clinical trial to develop a downstaging prediction model for hepatocellular carcinoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: HCC - Hepatocellular Carcinoma | Status: NOT_YET_RECRUITING